• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

希腊人类利什曼病的流行病学,1981-2011 年。

Epidemiology of human leishmaniasis in Greece, 1981-2011.

机构信息

Department of Epidemiological Surveillance and Intervention, Hellenic Center for Disease Control and Prevention, Athens, Greece.

出版信息

Euro Surveill. 2013 Jul 18;18(29):20532.

PMID:23929118
Abstract

Leishmaniasis is endemic and mandatorily notifiable in Greece. Epidemiological surveillance data for leishmaniasis in Greece between 1981 and 2011 are presented. In 1998, the notification system began distinguishing between visceral and cutaneous leishmaniasis. The mean annual incidence of reported leishmaniasis cases between 1998 and 2011 was 0.36 per 100,000 population. Of a total 563 leishmaniasis cases reported after 1998, 523 (93%) were visceral leishmaniasis cases. Incidence of reported visceral leishmaniasis cases fluctuated during this period, generally decreasing after 2007, with a small re-increase in 2011. The mean annual incidence rate of reported visceral leishmaniasis cases was significantly higher in less than four year-olds (p <0.001). Leishmaniasis cases occurred both in the country mainland and islands. Between 1998 and 2011, Attica concentrated almost half of the reported visceral leishmaniasis cases, with incidence rates in western Attica and western Athens above 12.00 per 100,000 population. Compared to visceral leishmaniasis, cutaneous leishmaniasis had a rather sporadic distribution, with many prefectures appearing free of cases. From 2004, the notification also included risk factors and of 287 cases with known immune status, 44 (15%) were immunocompromised. Moreover having a dog at home was reported by 209 of 312 leishmaniasis cases (67%), whereas 229 of 307 cases (75%) reported the presence of stray dogs near their residence. Linking clinical surveillance data with laboratory data and improving collaboration with the veterinary public health sector are some of the future challenges for leishmaniasis surveillance in Greece.

摘要

利什曼病在希腊流行,且须强制报告。现呈现希腊 1981 年至 2011 年利什曼病的流行病学监测数据。1998 年,报告系统开始区分内脏利什曼病和皮肤利什曼病。1998 年至 2011 年报告的利什曼病病例的年平均发病率为每 10 万人 0.36 例。在 1998 年后报告的总共 563 例利什曼病病例中,523 例(93%)为内脏利什曼病病例。在此期间,报告的内脏利什曼病病例的发病率波动不定,一般在 2007 年后降低,2011 年略有回升。小于 4 岁儿童的报告内脏利什曼病病例的年平均发病率明显较高(p<0.001)。利什曼病病例发生在大陆和岛屿。在 1998 年至 2011 年期间,阿提卡大区集中了近一半的报告内脏利什曼病病例,西部阿提卡和雅典西部的发病率高于每 10 万人 12.00 例。与内脏利什曼病相比,皮肤利什曼病的分布较为分散,许多州似乎没有病例。从 2004 年起,通报还包括危险因素,在已知免疫状况的 287 例病例中,44 例(15%)免疫功能低下。此外,312 例利什曼病病例中有 209 例(67%)报告家中有狗,而 307 例病例中有 229 例(75%)报告住所附近有流浪狗。将临床监测数据与实验室数据联系起来,并加强与兽医公共卫生部门的合作,是希腊利什曼病监测的未来挑战之一。

相似文献

1
Epidemiology of human leishmaniasis in Greece, 1981-2011.希腊人类利什曼病的流行病学,1981-2011 年。
Euro Surveill. 2013 Jul 18;18(29):20532.
2
Surveillance of leishmaniases in France, 1999 to 2012.法国 1999 年至 2012 年利什曼病监测情况。
Euro Surveill. 2013 Jul 18;18(29):20534.
3
Geographical distribution and epidemiological characteristics of visceral leishmaniasis in Bulgaria, 1988 to 2012.1988 年至 2012 年保加利亚内脏利什曼病的地理分布和流行病学特征。
Euro Surveill. 2013 Jul 18;18(29):20531.
4
Epidemiology and direct medical costs of human leishmaniasis in Italy.意大利人体利什曼病的流行病学与直接医疗成本
J Prev Med Hyg. 2007 Mar;48(1):27-36.
5
Surveillance for laboratory-confirmed sporadic cases of cyclosporiasis--United States, 1997-2008.对环孢子虫病散发病例的实验室监测 - 美国,1997-2008 年。
MMWR Surveill Summ. 2011 Apr 8;60(2):1-11.
6
Environmental parameters as risk factors for human and canine Leishmania infection in Thessaly, Central Greece.希腊中部色萨利地区环境参数作为人类和犬类利什曼原虫感染的风险因素
Parasitology. 2016 Aug;143(9):1179-86. doi: 10.1017/S0031182016000378. Epub 2016 May 25.
7
Surveillance data for human leishmaniasis indicate the need for a sustainable action plan for its management and control, Greece, 2004 to 2018.2004年至2018年希腊人体利什曼病监测数据表明,需要制定一项可持续的管理和控制行动计划。
Euro Surveill. 2021 May;26(18). doi: 10.2807/1560-7917.ES.2021.26.18.2000159.
8
Human and canine leishmaniasis in asymptomatic and symptomatic population in Northwestern Greece.希腊西北部无症状和有症状人群中的人类和犬类利什曼病
J Infect. 2005 Jan;50(1):53-60. doi: 10.1016/j.jinf.2004.05.004.
9
[Trends in incidence of cutaneous leishmaniasis from 1999 to 2005 in Ouagadougou, Burkina].[1999年至2005年布基纳法索瓦加杜古皮肤利什曼病发病率趋势]
Med Trop (Mars). 2011 Jun;71(3):312.
10
The incidence of cutaneous melanoma on Crete, Greece.希腊克里特岛皮肤黑色素瘤的发病率。
Int J Dermatol. 2006 Apr;45(4):397-401. doi: 10.1111/j.1365-4632.2006.02492.x.

引用本文的文献

1
Leishmaniasis in Greece: Prospects of transitioning to a One Health surveillance system.希腊的利什曼病:向“同一健康”监测系统过渡的前景
One Health. 2024 Sep 17;19:100896. doi: 10.1016/j.onehlt.2024.100896. eCollection 2024 Dec.
2
A Retrospective Study of Genetic Characterization in Suspected Visceral Leishmaniasis Cases in Greece, 2005 to 2020.2005年至2020年希腊疑似内脏利什曼病病例基因特征的回顾性研究
Pathogens. 2024 Aug 14;13(8):688. doi: 10.3390/pathogens13080688.
3
Alternative hosts of Leishmania infantum: a neglected parasite in Europe.
利什曼原虫的替代宿主:欧洲被忽视的寄生虫。
Trop Anim Health Prod. 2024 Apr 17;56(4):128. doi: 10.1007/s11250-024-03978-0.
4
The estimated distribution of autochthonous leishmaniasis by Leishmania infantum in Europe in 2005-2020.2005-2020 年欧洲利什曼原虫所致地方性利什曼病的估计分布。
PLoS Negl Trop Dis. 2023 Jul 19;17(7):e0011497. doi: 10.1371/journal.pntd.0011497. eCollection 2023 Jul.
5
Molecular Survey of Dirofilaria and Leishmania Species in Dogs from Central Balkan.巴尔干半岛中部犬类体内恶丝虫和利什曼原虫种类的分子调查
Animals (Basel). 2022 Apr 2;12(7):911. doi: 10.3390/ani12070911.
6
Estimating human leishmaniasis burden in Spain using the capture-recapture method, 2016-2017.利用捕获-再捕获法估计 2016-2017 年西班牙的人体利什曼病负担。
PLoS One. 2021 Oct 29;16(10):e0259225. doi: 10.1371/journal.pone.0259225. eCollection 2021.
7
Bioprospecting marine actinomycetes for antileishmanial drugs: current perspectives and future prospects.海洋放线菌用于抗利什曼原虫药物的生物勘探:当前观点与未来展望
Heliyon. 2021 Aug 2;7(8):e07710. doi: 10.1016/j.heliyon.2021.e07710. eCollection 2021 Aug.
8
Surveillance data for human leishmaniasis indicate the need for a sustainable action plan for its management and control, Greece, 2004 to 2018.2004年至2018年希腊人体利什曼病监测数据表明,需要制定一项可持续的管理和控制行动计划。
Euro Surveill. 2021 May;26(18). doi: 10.2807/1560-7917.ES.2021.26.18.2000159.
9
Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran.伊朗东南部一个主要疫源地中无反应型和有反应型患者的人源性皮肤利什曼病危险因素。
PLoS One. 2018 Feb 7;13(2):e0192236. doi: 10.1371/journal.pone.0192236. eCollection 2018.
10
Phlebotomine sand fly-borne pathogens in the Mediterranean Basin: Human leishmaniasis and phlebovirus infections.地中海盆地白蛉传播的病原体:人类利什曼病和白蛉病毒感染
PLoS Negl Trop Dis. 2017 Aug 10;11(8):e0005660. doi: 10.1371/journal.pntd.0005660. eCollection 2017 Aug.